Dermatophytosis: Market View

This reports provides a data-driven overview of the current and future competitive landscape in dermatophytosis Therapeutics.

India is projected to have the highest number of diagnosed prevalent cases of dermatophytosis in both 2024 and 2029, contributing 32.28% and 32.98% of cases, respectively.

The dermatophytosis treatment market is largely saturated with generics, with antifungal agents comprising the majority of approved innovator drugs currently available.

The pipeline for dermatophytosis remains limited, with no drug in the pre-registration stage, one drug in Phase III, and three drugs in Phase II.

Over the past decade, 210 clinical trials were initiated for dermatophytosis. The years with the most trials initiated in dermatophytosis were 2023 with 36 trials, followed by 2022 and 2019 with 23 and 22 trials, respectively.

In the past two years, one strategic alliance involving companies developing dermatophytosis assets has been completed, nine mergers and acquisition deals have been completed, and eight merger and acquisitions have been announced.

Scope

The dermatophytosis: Market View combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include:

• Disease Landscape
• Disease Overview
• Epidemiology Overview
• Treatment Overview
• Marketed Products Assessment
• Breakdown by Mechanism of Action, Route of Administration
• Product Profiles with Sales Forecast
• Pricing and Reimbursement Assessment
• Annual Therapy Cost
• Time to Pricing and Time to Reimbursement
• Pipeline Assessment
• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
• Product Profiles with Sales Forecast
• Late-to-mid-stage Pipeline Drugs
• Phase Transition Success Rate and Likelihood of Approval
• Clinical Trials Assessment
• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
• Enrolment Analytics, Site Analytics, Feasibility Analysis
• Deals Landscape
• Mergers, Acquisitions, and Strategic Alliances by Region
• Overview of Recent Deals
• Commercial Assessment
• Key Market Players
• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the dermatophytosis Therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, and companies likely to impact the global dermatophytosis Therapeutics market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories that present the maximum opportunities for consolidations, investments, and strategic partnerships.